VKTX · Viking Therapeutics, Inc.
Market Cap
$4.07B
Shares
116.65M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1607678
CUSIP
92686J106
13F (30d)
279 filings
274 filers
Visit website
Investor relations